Ramelteon in the Prevention of Post-operative Delirium
Status:
Completed
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness
and safety of peri-operative administration of ramelteon, a melatonin agonist in the
prevention of postoperative delirium.